Bio-Techne Corporation Revenue 2009–2025
Bio-Techne Corporation annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bio-Techne Corporation revenue for the quarter ending March 31, 2026 was 311.4 M, a 1.51% decrease year-over-year.
- Bio-Techne Corporation revenue for the twelve months ending March 31, 2026 was 1.2 B, a 4.09% increase year-over-year.
- Bio-Techne Corporation annual revenue for 2025 was 1.2 B, a 5.23% increase from 2024.
- Bio-Techne Corporation annual revenue for 2024 was 1.2 B, a 1.97% increase from 2023.
- Bio-Techne Corporation annual revenue for 2023 was 1.1 B, a 2.81% increase from 2022.
- Bio-Techne Corporation annual revenue for 2022 was 1.1 B.
Bio-Techne Corporation (TECH) — Frequently Asked Questions
Bio-Techne Corporation (TECH) is a publicly traded US company. It has a market capitalization of $8.39B. In fiscal 2025 it reported revenue of $1.22B and net income of $73M. Explore TECH's stock price, financial statements, earnings history, margins and key ratios below.
What is Bio-Techne Corporation's market cap?
Bio-Techne Corporation (TECH) has a market capitalization of $8.39B.
What is the TECH stock price?
TECH trades at $52.50 (-3.51% on the day).
How much revenue does Bio-Techne Corporation make?
Bio-Techne Corporation reported revenue of $1.22B in fiscal 2025.
Is TECH profitable?
In fiscal 2025, Bio-Techne Corporation reported net income of $73M.
What is TECH's P/E ratio?
Based on diluted EPS, TECH has a price-to-earnings (P/E) ratio of about 114.1.